{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:21:20Z","timestamp":1794007280842,"version":"4.8.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>\n                    <jats:bold>Abstract<\/jats:bold>\n                  <\/jats:title>\n                  <jats:p>Intrathecal delivery of autologous culture-expanded adipose tissue-derived mesenchymal stem cells (AD-MSC) could be utilized to treat traumatic spinal cord injury (SCI). This Phase I trial (ClinicalTrials.gov: NCT03308565) included 10 patients with American Spinal Injury Association Impairment Scale (AIS) grade A or B at the time of injury. The study\u2019s primary outcome was the safety profile, as captured by the nature and frequency of adverse events. Secondary outcomes included changes in sensory and motor scores, imaging, cerebrospinal fluid markers, and somatosensory evoked potentials. The manufacturing and delivery of the regimen were successful for all patients. The most commonly reported adverse events were headache and musculoskeletal pain, observed in 8 patients. No serious AEs were observed. At final follow-up, seven patients demonstrated improvement in AIS grade from the time of injection. In conclusion, the study met the primary endpoint, demonstrating that AD-MSC harvesting and administration were well-tolerated in patients with traumatic SCI.<\/jats:p>","DOI":"10.1038\/s41467-024-46259-y","type":"journal-article","created":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T05:13:50Z","timestamp":1711948430000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Intrathecal delivery of adipose-derived mesenchymal stem cells in traumatic spinal cord injury: Phase I trial"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0543-396X","authenticated-orcid":false,"given":"Mohamad","family":"Bydon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. M.","family":"Moinuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L.","family":"Garlanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald K.","family":"Reeves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Windebank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin D.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Jarrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon C.","family":"Trammell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"El Sammak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7473-7262","authenticated-orcid":false,"given":"Giorgos D.","family":"Michalopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Katsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Graepel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly L.","family":"Seidel-Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1884-5824","authenticated-orcid":false,"given":"Ruple S.","family":"Laughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3410-9621","authenticated-orcid":false,"given":"Allan B.","family":"Dietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,1]]},"reference":[{"key":"46259_CR1","doi-asserted-by":"crossref","unstructured":"Spinal Cord Injury (SCI) Facts and Figures at a Glance. The Journal of Spinal Cord Medicine. 39(3):370-371 (2016).","DOI":"10.1080\/10790268.2016.1177348"},{"key":"46259_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1038\/nrn1955","volume":"7","author":"S Thuret","year":"2006","unstructured":"Thuret, S., Moon, L. D. & Gage, F. H. Therapeutic interventions after spinal cord injury. Nat. Rev. Neurosci. 7, 628\u2013643 (2006).","journal-title":"Nat. Rev. Neurosci."},{"key":"46259_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6940283","volume":"2016","author":"RS Mahla","year":"2016","unstructured":"Mahla, R. S. Stem cells applications in regenerative medicine and disease therapeutics. Int. J. Cell Biol. 2016, 6940283 (2016).","journal-title":"Int. J. Cell Biol."},{"key":"46259_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.21037\/sci.2019.06.04","volume":"6","author":"N Rajabzadeh","year":"2019","unstructured":"Rajabzadeh, N., Fathi, E. & Farahzadi, R. Stem cell-based regenerative medicine. Stem Cell Investig. 6, 19 (2019).","journal-title":"Stem Cell Investig."},{"key":"46259_CR5","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/nn.4541","volume":"20","author":"P Assinck","year":"2017","unstructured":"Assinck, P., Duncan, G. J., Hilton, B. J., Plemel, J. R. & Tetzlaff, W. Cell transplantation therapy for spinal cord injury. Nat. Neurosci. 20, 637\u2013647 (2017).","journal-title":"Nat. Neurosci."},{"key":"46259_CR6","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/nprot.2010.81","volume":"5","author":"BT Estes","year":"2010","unstructured":"Estes, B. T., Diekman, B. O., Gimble, J. M. & Guilak, F. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat. Protoc. 5, 1294\u20131311 (2010).","journal-title":"Nat. Protoc."},{"key":"46259_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13287-020-01724-5","volume":"11","author":"Z Zhou","year":"2020","unstructured":"Zhou, Z. et al. Adipose mesenchymal stem cell transplantation alleviates spinal cord injury-induced neuroinflammation partly by suppressing the Jagged1\/Notch pathway. Stem Cell Res. Ther. 11, 212 (2020).","journal-title":"Stem Cell Res. Ther."},{"key":"46259_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/jsp2.1072","volume":"2","author":"ALA Binch","year":"2019","unstructured":"Binch, A. L. A., Richardson, S. M., Hoyland, J. A. & Barry, F. P. Combinatorial conditioning of adipose derived-mesenchymal stem cells enhances their neurovascular potential: Implications for intervertebral disc degeneration. JOR Spine 2, e1072 (2019).","journal-title":"JOR Spine"},{"key":"46259_CR9","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s10571-011-9712-3","volume":"31","author":"D Arboleda","year":"2011","unstructured":"Arboleda, D. et al. Transplantation of predifferentiated adipose-derived stromal cells for the treatment of spinal cord injury. Cell. Mol. Neurobiol. 31, 1113\u20131122 (2011).","journal-title":"Cell. Mol. Neurobiol."},{"key":"46259_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3340\/jkns.2016.1010.008","volume":"60","author":"J Min","year":"2017","unstructured":"Min, J., Kim, J. H., Choi, K. H., Yoon, H. H. & Jeon, S. R. Is there additive therapeutic effect when gcsf combined with adipose-derived stem cell in a rat model of acute spinal cord injury? J. Korean Neurosurg. Soc. 60, 404\u2013416 (2017).","journal-title":"J. Korean Neurosurg. Soc."},{"key":"46259_CR11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s10571-015-0246-y","volume":"36","author":"L Tang","year":"2016","unstructured":"Tang, L. et al. Adipose-derived stem cells expressing the Neurogenin-2 promote functional recovery after spinal cord injury in rat. Cell. Mol. Neurobiol. 36, 657\u2013667 (2016).","journal-title":"Cell. Mol. Neurobiol."},{"key":"46259_CR12","first-page":"127","volume":"26","author":"Y Aras","year":"2016","unstructured":"Aras, Y. et al. The effects of adipose tissue-derived mesenchymal stem cell transplantation during the acute and subacute phases following spinal cord injury. Turkish Neurosurg. 26, 127\u2013139 (2016).","journal-title":"Turkish Neurosurg."},{"key":"46259_CR13","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.4103\/1673-5374.133159","volume":"9","author":"A Abdanipour","year":"2014","unstructured":"Abdanipour, A., Tiraihi, T. & Taheri, T. Intraspinal transplantation of motoneuron-like cell combined with delivery of polymer-based glial cell line-derived neurotrophic factor for repair of spinal cord contusion injury. Neural Regen. Res. 9, 1003\u20131013 (2014).","journal-title":"Neural Regen. Res."},{"key":"46259_CR14","first-page":"3205","volume":"35","author":"PR Slud Brofman","year":"2014","unstructured":"Slud Brofman, P. R. et al. Effect of mesenchymal stem cells on movement and urination of rats with spinal cord injury. Semina: Ci\u00eancias Agr. \u00e1rias 35, 3205\u20133214 (2014).","journal-title":"Semina: Ci\u00eancias Agr. \u00e1rias"},{"key":"46259_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.npep.2016.07.004","volume":"61","author":"A Sarveazad","year":"2017","unstructured":"Sarveazad, A. et al. The combined application of human adipose derived stem cells and chondroitinase ABC in treatment of a spinal cord injury model. Neuropeptides 61, 39\u201347 (2017).","journal-title":"Neuropeptides"},{"key":"46259_CR16","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.mayocp.2019.10.008","volume":"95","author":"M Bydon","year":"2020","unstructured":"Bydon, M. et al. CELLTOP clinical trial: first report from a Phase 1 trial of autologous adipose tissue-derived mesenchymal stem cells in the treatment of paralysis due to traumatic spinal cord injury. Mayo Clin. Proc. 95, 406\u2013414 (2020).","journal-title":"Mayo Clin. Proc."},{"key":"46259_CR17","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.clinph.2008.03.016","volume":"119","author":"G Cruccu","year":"2008","unstructured":"Cruccu, G. et al. Recommendations for the clinical use of somatosensory-evoked potentials. Clin. Neurophysiol. 119, 1705\u20131719 (2008).","journal-title":"Clin. Neurophysiol."},{"key":"46259_CR18","doi-asserted-by":"publisher","first-page":"S232","DOI":"10.1007\/s00586-007-0421-z","volume":"16","author":"M Sutter","year":"2007","unstructured":"Sutter, M. et al. Current opinions and recommendations on multimodal intraoperative monitoring during spine surgeries. Eur. Spine J. 16, S232\u2013237 (2007).","journal-title":"Eur. Spine J."},{"key":"46259_CR19","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/STROKEAHA.113.004075","volume":"45","author":"U Dirnagl","year":"2014","unstructured":"Dirnagl, U. & Endres, M. Found in translation: preclinical stroke research predicts human pathophysiology, clinical phenotypes, and therapeutic outcomes. Stroke 45, 1510\u20131518 (2014).","journal-title":"Stroke"},{"key":"46259_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01771-w","volume":"10","author":"SN Rafiei Alavi","year":"2021","unstructured":"Rafiei Alavi, S. N., Madani Neishaboori, A., Hossein, H., Sarveazad, A. & Yousefifard, M. Efficacy of adipose tissue-derived stem cells in locomotion recovery after spinal cord injury: a systematic review and meta-analysis on animal studies. Syst. Rev. 10, 213 (2021).","journal-title":"Syst. Rev."},{"key":"46259_CR21","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1179\/2045772315Y.0000000048","volume":"39","author":"JW Hur","year":"2016","unstructured":"Hur, J. W., Cho, T. H., Park, D. H., Lee, J. B., Park, J. Y. & Chung, Y. G. Intrathecal transplantation of autologous adipose-derived mesenchymal stem cells for treating spinal cord injury: a human trial. J. Spinal Cord. Med 39, 655\u2013664 (2016).","journal-title":"J. Spinal Cord. Med"},{"key":"46259_CR22","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1212\/WNL.0000000000003359","volume":"87","author":"NP Staff","year":"2016","unstructured":"Staff, N. P. et al. Safety of intrathecal autologous adipose-derived mesenchymal stromal cells in patients with ALS. Neurology 87, 2230\u20132234 (2016).","journal-title":"Neurology"},{"key":"46259_CR23","doi-asserted-by":"publisher","first-page":"590","DOI":"10.5966\/sctm.2014-0212","volume":"4","author":"KW Oh","year":"2015","unstructured":"Oh, K. W. et al. Phase I trial of repeated intrathecal autologous bone marrow-derived mesenchymal stromal cells in amyotrophic lateral sclerosis. Stem Cells Transl. Med. 4, 590\u2013597 (2015).","journal-title":"Stem Cells Transl. Med."},{"key":"46259_CR24","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/archneurol.2010.248","volume":"67","author":"D Karussis","year":"2010","unstructured":"Karussis, D. et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol. 67, 1187\u20131194 (2010).","journal-title":"Arch. Neurol."},{"key":"46259_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1177\/1971400920902451","volume":"33","author":"AA Madhavan","year":"2020","unstructured":"Madhavan, A. A. et al. Polyclonal lymphocytic infiltrate with arachnoiditis resulting from intrathecal stem cell transplantation. Neuroradiol. J. 33, 174\u2013178 (2020).","journal-title":"Neuroradiol. J."},{"key":"46259_CR26","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.radcr.2022.02.021","volume":"17","author":"AD Brumbaugh","year":"2022","unstructured":"Brumbaugh, A. D. et al. Stem cell induced inflammatory hypertrophy of the cauda equina. Radio. Case Rep. 17, 1601\u20131604 (2022).","journal-title":"Radio. Case Rep."},{"key":"46259_CR27","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1002\/mus.23920","volume":"48","author":"RW Hurst","year":"2013","unstructured":"Hurst, R. W., Bosch, E. P., Morris, J. M., Dyck, P. J. & Reeves, R. K. Inflammatory hypertrophic cauda equina following intrathecal neural stem cell injection. Muscle Nerve 48, 831\u2013835 (2013).","journal-title":"Muscle Nerve"},{"key":"46259_CR28","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1212\/WNL.0000000000007720","volume":"93","author":"W Singer","year":"2019","unstructured":"Singer, W. et al. Intrathecal administration of autologous mesenchymal stem cells in multiple system atrophy. Neurology 93, e77\u2013e87 (2019).","journal-title":"Neurology"},{"key":"46259_CR29","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1089\/neu.2020.7473","volume":"38","author":"S Kirshblum","year":"2021","unstructured":"Kirshblum, S., Snider, B., Eren, F. & Guest, J. Characterizing natural recovery after traumatic spinal cord injury. J. neurotrauma 38, 1267\u20131284 (2021).","journal-title":"J. neurotrauma"},{"key":"46259_CR30","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.apmr.2004.03.015","volume":"85","author":"S Kirshblum","year":"2004","unstructured":"Kirshblum, S., Millis, S., McKinley, W. & Tulsky, D. Late neurologic recovery after traumatic spinal cord injury. Arch. Phys. Med. Rehabilit. 85, 1811\u20131817 (2004).","journal-title":"Arch. Phys. Med. Rehabilit."},{"key":"46259_CR31","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ni.3002","volume":"15","author":"Y Wang","year":"2014","unstructured":"Wang, Y., Chen, X., Cao, W. & Shi, Y. Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications. Nat. Immunol. 15, 1009\u20131016 (2014).","journal-title":"Nat. Immunol."},{"key":"46259_CR32","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1038\/nature04478","volume":"438","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet, P. Angiogenesis in life, disease and medicine. Nature 438, 932\u2013936 (2005).","journal-title":"Nature"},{"key":"46259_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02337-2","volume":"18","author":"DJ Hellenbrand","year":"2021","unstructured":"Hellenbrand, D. J., Quinn, C. M., Piper, Z. J., Morehouse, C. N., Fixel, J. A. & Hanna, A. S. Inflammation after spinal cord injury: a review of the critical timeline of signaling cues and cellular infiltration. J. Neuroinflam. 18, 284 (2021).","journal-title":"J. Neuroinflam."},{"key":"46259_CR34","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1089\/neu.2017.5063","volume":"34","author":"JH Huang","year":"2017","unstructured":"Huang, J. H. et al. Systemic administration of exosomes released from mesenchymal stromal cells attenuates apoptosis, inflammation, and promotes angiogenesis after spinal cord injury in rats. J. Neurotrauma 34, 3388\u20133396 (2017).","journal-title":"J. Neurotrauma"},{"key":"46259_CR35","doi-asserted-by":"publisher","first-page":"904","DOI":"10.2106\/JBJS.18.00915","volume":"101","author":"IR Murray","year":"2019","unstructured":"Murray, I. R. et al. International expert consensus on a cell therapy communication tool: DOSES. J. Bone Jt. Surg. Am. 101, 904\u2013911 (2019).","journal-title":"J. Bone Jt. Surg. Am."},{"key":"46259_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici, M. et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315\u2013317 (2006).","journal-title":"Cytotherapy"},{"key":"46259_CR37","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s11999-016-5133-4","volume":"475","author":"TT Roberts","year":"2017","unstructured":"Roberts, T. T., Leonard, G. R. & Cepela, D. J. Classifications in brief: American spinal injury association (ASIA) impairment scale. Clin. Orthop. Relat. Res. 475, 1499\u20131504 (2017).","journal-title":"Clin. Orthop. Relat. Res."}],"updated-by":[{"DOI":"10.1038\/s41467-024-48979-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46259-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46259-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46259-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T02:02:27Z","timestamp":1717639347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-46259-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["46259"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-46259-y","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,1]]},"assertion":[{"value":"11 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-024-48979-7","URL":"https:\/\/doi.org\/10.1038\/s41467-024-48979-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2201"}}